Rhythm Pharmaceuticals Presents Patient-reported
Rhythm presents first-ever hypothalamic obesity patient-reported experiences with hyperphagia and positive changes in energy and sleep at ENDO2024 ...
Source: globenewswire.com
Stay updated with breaking news from Translational Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhythm presents first-ever hypothalamic obesity patient-reported experiences with hyperphagia and positive changes in energy and sleep at ENDO2024 ...
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results SAN DIEGO, November 2, 2023- Cidara Therapeutics, Inc. , a biotechnology company...
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted th...